Complete Guide to Tirzepatide: Everything You Need to Know

Quick Answer: Tirzepatide is a dual GIP/GLP-1 receptor agonist medication. FDA-approved versions (Mounjaro, Zepbound) demonstrated significant weight loss in clinical trials. Important: Compounded tirzepatide is NOT FDA-approved. The FDA does not verify the safety or effectiveness of compounded medications. Individual results vary significantly and are not guaranteed. Clinical trial data applies only to FDA-approved brand-name medications and may not apply to compounded tirzepatide. Tirzepatide carries an FDA boxed warning for possible thyroid C-cell tumors; discuss your risk with your clinician.

What Is Tirzepatide?

Tirzepatide is a weight management medication that represents a newer class beyond semaglutide and other GLP-1 medications. While semaglutide mimics one hormone (GLP-1), tirzepatide is a dual-action medication that mimics both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). In head-to-head trials of the branded products, tirzepatide produced greater average weight loss than other approved GLP-1 medications.

Originally developed for type 2 diabetes treatment, tirzepatide is available as FDA-approved Mounjaro and Zepbound. Important: Compounded tirzepatide is NOT FDA-approved. The FDA does not verify the safety or effectiveness of compounded medications. Clinical trial data applies only to FDA-approved brands and may not apply to compounded tirzepatide.

Brand Names and Availability

Mounjaro®: FDA-approved for type 2 diabetes (May 2022)

• Manufactured by Eli Lilly
• Available in 5 dose strengths (2.5 mg to 15 mg)
• Often prescribed off-label for weight loss

Zepbound®: FDA-approved for chronic weight management (November 2023)

• FDA-approved for weight loss
• Specifically approved for weight loss in adults with obesity or overweight with weight-related conditions
• Available in 6 dose strengths (2.5 mg to 15 mg)

Compounded Tirzepatide: Available from specialized compounding pharmacies

• Compounded tirzepatide is NOT FDA-approved
• NOT FDA-approved - FDA does not verify safety or effectiveness
• Regulatory status may change - consult healthcare provider
• Clinical trial data applies only to FDA-approved products, not compounded versions

How Tirzepatide Works

Tirzepatide’s dual-action mechanism sets it apart from single-hormone medications like semaglutide:

GLP-1 Receptor Activation (Glucagon-Like Peptide-1)

Appetite Suppression:

• Activates GLP-1 receptors in the brain’s appetite control centers
• Reduces hunger signals
• Increases feelings of fullness after meals
• Reduces food cravings and reward value of eating

Gastric Effects:

• Slows gastric emptying (food stays in stomach longer)
• Prolongs satiety between meals
• Reduces portion sizes naturally

Metabolic Benefits:

• Enhances insulin secretion when blood sugar is elevated
• Suppresses glucagon (hormone that raises blood sugar)
• Improves blood sugar control in people with diabetes

GIP Receptor Activation (Glucose-Dependent Insulinotropic Polypeptide)

This second mechanism is what distinguishes tirzepatide from GLP-1-only medications such as semaglutide:

Enhanced Metabolic Effects:

• Further amplifies insulin secretion
• May influence fat metabolism and energy expenditure
• May enhance the effects of GLP-1 activation
• May help preserve lean muscle mass during weight loss

Additional Benefits:

• May improve lipid profiles (cholesterol and triglycerides)
• Potential cardiovascular benefits being studied
• May support overall metabolic health

The Synergistic Effect

The combination of GIP and GLP-1 activation is thought to create a synergistic effect that produces greater weight loss than would be expected from either hormone alone. In head-to-head trials of the FDA-approved branded products, this dual mechanism is associated with greater average weight loss than GLP-1-only medications. These findings reflect FDA-approved products and may not apply to compounded tirzepatide.

How Effective Is Tirzepatide for Weight Loss?

In head-to-head trials of the branded products, tirzepatide produced greater average weight loss than other approved GLP-1 medications. The figures below come from trials of FDA-approved tirzepatide (Mounjaro, Zepbound). Individual results vary, are not guaranteed, and may not apply to compounded tirzepatide.

SURMOUNT Clinical Trial Results (FDA-Approved Tirzepatide)

The SURMOUNT-1 trial tested FDA-approved tirzepatide specifically for weight loss in people without diabetes over 72 weeks. At the highest dose, participants lost approximately 22.5% of body weight on average. These are FDA-approved-product trial results; individual results vary and may not apply to compounded tirzepatide.

Dose (FDA-Approved Product)	Average Weight Loss (SURMOUNT-1)	% Losing 20%+	% Losing 25%+
5 mg	16.1% of body weight	30%	14%
10 mg	21.4% of body weight	55%	32%
15 mg	22.5% of body weight	63%	40%
Placebo	2.4% of body weight	1%	0%

What These Percentages Can Mean (Illustrative Only)

The examples below simply apply the SURMOUNT-1 average percentages above to sample starting weights. They are illustrative averages from trials of FDA-approved tirzepatide, not predictions. Individual results vary, are not guaranteed, and may not apply to compounded tirzepatide.

Starting Weight: 250 pounds (applying trial averages)

• 10 mg average (21.4%): about 54 pounds
• 15 mg average (22.5%): about 56 pounds

Starting Weight: 200 pounds (applying trial averages)

• 10 mg average (21.4%): about 43 pounds
• 15 mg average (22.5%): about 45 pounds

How FDA-Approved Tirzepatide Compared to Other Treatments in Trials

The figures below are drawn from separate clinical trials of FDA-approved products and are not direct head-to-head comparisons except where noted. Trial designs, populations, and durations differ.

Treatment (FDA-Approved Product)	Average Weight Loss in Trials	Study Duration
Tirzepatide 15 mg	~22.5%	72 weeks
Semaglutide 2.4 mg	15-17%	68 weeks
Liraglutide 3.0 mg	8-9%	56 weeks
Phentermine/Topiramate	10-11%	52 weeks
Bariatric Surgery	25-30%	12 months

In trials of FDA-approved products, average weight loss with tirzepatide 15 mg was in a range that approached results reported for bariatric surgery, without requiring an invasive procedure. These are averages from separate studies; individual results vary and may not apply to compounded tirzepatide.

Beyond Weight Loss: Additional Health Markers

In clinical trials of FDA-approved tirzepatide, researchers observed average improvements in several health markers. Individual results vary and these findings may not apply to compounded tirzepatide:

• Blood Pressure: Average reduction of 7-9 mmHg systolic
• Blood Sugar (HbA1c): Reduction of 2.0-2.5% in people with diabetes
• Triglycerides: Average reduction of 20-30%
• LDL Cholesterol: Modest reductions of 5-10%
• Liver Fat: Reductions in people with fatty liver disease
• Inflammation Markers: Reductions in C-reactive protein and other inflammatory markers

Tirzepatide vs Semaglutide: Key Differences

Both medications are used for weight management. In the SURMOUNT-5 head-to-head trial of the FDA-approved branded products, tirzepatide produced greater average weight loss than semaglutide (Aronne LJ et al., N Engl J Med, 2025, doi:10.1056/NEJMoa2416394). These comparisons apply to FDA-approved products and may not apply to compounded versions of either drug. Important differences to consider:

Feature	Tirzepatide	Semaglutide
Mechanism	Dual GIP/GLP-1 agonist	GLP-1 agonist only
Average Weight Loss	Greater in head-to-head trials of FDA-approved brands	Clinical data for FDA-approved brands
Maximum Dose	15 mg weekly	2.4 mg weekly
Nausea Rate	Moderate (30-40%)	Moderate (40-50%)
Brand Cost	$1,060-1,200/month	$1,350-1,600/month
Dosing	Once weekly injection	Once weekly injection

When to Discuss Tirzepatide With Your Clinician

Tirzepatide may be worth discussing with your provider if:

• You are looking for an option that produced greater average weight loss than semaglutide in head-to-head trials of the FDA-approved brands
• You have significant weight to lose (50+ pounds)
• You’ve tried semaglutide and plateaued or had modest results
• You have type 2 diabetes and need better glucose control
• You and your clinician decide it is appropriate for your situation

The right medication depends on your health history, goals, and your clinician’s judgment. For a detailed comparison of effectiveness, side effects, and costs, see our comprehensive tirzepatide vs semaglutide comparison.

Who Qualifies for Tirzepatide?

FDA-Approved Indications

Zepbound (Weight Loss):

• BMI ≥ 30 (obesity), OR
• BMI ≥ 27 with at least one weight-related health condition:
  • High blood pressure
  • Type 2 diabetes
  • High cholesterol
  • Obstructive sleep apnea
  • Cardiovascular disease
• Age 18 or older

Mounjaro (Type 2 Diabetes):

• Diagnosed type 2 diabetes
• Age 18 or older
• Often prescribed off-label for weight loss

Who Should NOT Use Tirzepatide

Absolute Contraindications:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Pregnancy or breastfeeding (stop 2 months before conception attempt)
• Known allergy to tirzepatide or any ingredient

Tirzepatide carries an FDA boxed warning for possible thyroid C-cell tumors based on animal studies; it is contraindicated in people with a personal or family history of MTC or MEN 2. See the Safety and Contraindications section below for full details.

Relative Contraindications (Use with Caution):

• History of pancreatitis
• Severe gastrointestinal disease
• Diabetic retinopathy (may worsen temporarily)
• History of gallbladder disease
• Severe kidney disease

Special Populations

Older Adults (65+):

• May need slower dose escalation
• Increased risk of dehydration and gastrointestinal side effects
• May need closer monitoring

People with Kidney Disease:

• Mild to moderate kidney disease: Usually used with monitoring
• Severe kidney disease: Limited data, use with caution
• Dialysis: Not studied, generally not recommended

How to Use Tirzepatide

Injection Basics

Tirzepatide is administered as a subcutaneous (under the skin) injection once weekly, on the same day each week. The injection is generally well tolerated and can be self-administered at home after instruction from your provider.

Injection Sites:

• Abdomen: Most common site, good absorption (avoid 2 inches around belly button)
• Thigh: Front and outer areas of thigh
• Upper Arm: Back of upper arm (may need assistance)

Rotation is Important:

• Rotate injection sites each week
• Use different areas within each region
• Don’t inject into the same exact spot more than once per month
• This helps prevent lipodystrophy (fat tissue changes)

Administration Steps

1. Prepare: Let pen reach room temperature (15-30 minutes)
2. Check: Inspect solution (should be clear and colorless)
3. Clean: Wipe injection site with alcohol swab, let dry
4. Inject: Pinch skin, insert needle at 90-degree angle, press button
5. Hold: Keep button pressed for 5-10 seconds
6. Remove: Pull out needle, dispose in sharps container
7. Discard: Single-use pens should be discarded after use

Always follow the specific instructions provided with your medication and by your clinician, as devices and products differ.

Timing and Consistency

Best Practices:

• Choose a consistent day and time each week
• Can be taken with or without food
• Morning injections may help if nausea is an issue
• Evening injections may help if you experience fatigue

What if you miss a dose?

• If less than 4 days late: Take as soon as you remember
• If more than 4 days late: Skip the missed dose, resume regular schedule
• Never double up doses
• Follow your clinician’s guidance and the product instructions. For more, see our article on what to do if you miss a tirzepatide dose

Tirzepatide Dosing Schedule

Tirzepatide typically requires a gradual dose escalation to help reduce side effects and allow your body to adjust. Dosing is directed by your clinician and may differ from the example below.

Example Dose Escalation Schedule (Clinician-Directed)

The schedule below reflects the FDA-approved labeling for branded tirzepatide and is provided for general education only. Your clinician will determine the right dose and pace for you.

Timeframe	Dose	What Some People Experience
Weeks 1-4	2.5 mg	Initial dose, mild appetite reduction, possible mild nausea, minimal weight loss
Weeks 5-8	5 mg	Noticeable appetite suppression, weight loss may begin, side effects may increase temporarily
Weeks 9-12	7.5 mg	Often more consistent weight loss, side effects typically stabilizing
Weeks 13-16	10 mg	Greater appetite suppression, steady weight loss for many people
Weeks 17-20	12.5 mg	Approaching higher doses
Week 21+	15 mg	Maximum labeled dose (if tolerated, needed, and directed by your clinician)

Dosing Flexibility

You and your clinician may decide to stay at a lower dose if:

• You’re achieving your weight loss goals
• Side effects are manageable at current dose but worsen with increases
• You’ve reached a satisfactory weight
• Your healthcare provider recommends it based on your individual response

Your clinician may adjust your dose if:

• Side effects are too severe (temporary dose reduction)
• Weight loss has plateaued for 8+ weeks (they may consider an increase)
• You have specific medical conditions requiring slower escalation

For a detailed week-by-week breakdown of what to expect, see our tirzepatide weight loss timeline guide.

Common Side Effects

Like other GLP-1 and GIP medications, tirzepatide commonly causes gastrointestinal side effects, especially during dose increases. For many people these are temporary and improve within 2-4 weeks, though experiences vary.

Very Common Side Effects (>10% of users)

Nausea (30-40% of users):

• Most common during first 2-4 weeks and after dose increases
• Usually mild to moderate intensity
• Often improves by weeks 3-4
• Management: Eat smaller meals, avoid greasy foods, ginger, stay hydrated

Diarrhea (20-30% of users):

• May occur intermittently
• Often resolves within 1-2 weeks
• Management: Increase fiber gradually, stay hydrated, avoid trigger foods

Decreased Appetite (Expected effect):

• This is the intended therapeutic effect
• Should feel like natural fullness, not illness
• Make sure to eat enough protein (80-100g daily minimum)

Common Side Effects (5-10% of users)

• Constipation: 10-15% of users
  • Management: Increase water, fiber, consider magnesium supplement
• Vomiting: 5-10% of users
  • Less common than nausea
  • Often related to eating too much too quickly
• Abdominal Pain/Discomfort: 8-12% of users
  • Usually mild, related to slowed gastric emptying
• Fatigue: 5-10% of users
  • May be related to calorie restriction
  • Often improves with adequate protein and nutrition
• Injection Site Reactions: 5-8% of users
  • Mild redness, itching, or swelling at injection site
  • Usually resolves within 24-48 hours

Less Common But Important Side Effects (1-5% of users)

• Hair Thinning: Temporary, related to rapid weight loss and nutritional factors
  • Usually resolves after weight stabilizes
  • May be minimized with adequate protein and biotin supplementation
• Heartburn/Reflux: Slowed gastric emptying can worsen GERD
  • Management: Smaller meals, avoid lying down after eating, antacids if needed
• Gallstones: ~1-2% (related to rapid weight loss, not unique to tirzepatide)
  • Risk factors: Very rapid weight loss, personal/family history of gallstones
• Hypoglycemia: Less common in people without diabetes
  • More common if taking with other diabetes medications

Rare But Serious Side Effects (<1%)

• Pancreatitis: approximately 0.1-0.2%
  • Symptoms: Severe, persistent abdominal pain radiating to back, nausea, vomiting
  • Requires immediate medical attention
• Severe Allergic Reactions: Rare
  • Symptoms: Swelling of face/throat, difficulty breathing, severe rash
  • Emergency medical attention required
• Thyroid C-cell tumors: See the FDA boxed warning in the Safety section. Contraindicated if you have a personal or family history of medullary thyroid carcinoma or MEN 2.

Managing Side Effects

For comprehensive strategies to manage tirzepatide side effects, including dietary recommendations and when to contact your doctor, see our complete guide to managing tirzepatide side effects.

Weight Loss Timeline

The pace of weight loss varies widely from person to person. The averages below are drawn from trials of FDA-approved tirzepatide and are not predictions for any individual. Individual results vary, are not guaranteed, and may not apply to compounded tirzepatide.

Month-by-Month Weight Loss Averages (FDA-Approved Product Trials)

Timeframe	Average Weight Loss	What’s Happening
Month 1	3-6 pounds (2-3%)	Starting dose (2.5 mg), initial adaptation, water weight, mild appetite reduction
Month 2	6-10 pounds (4-5% total)	Increased to 5 mg, noticeable appetite suppression, steady loss
Month 3	8-12 pounds (7-8% total)	Up to 7.5 mg, consistent weight loss, side effects stabilizing
Months 4-6	12-18 pounds (12-14% total)	Reaching 10-12.5 mg, peak weight loss rate for many people
Months 7-12	15-25 pounds (18-22% total)	At maintenance dose, continued steady loss, may experience plateaus
Months 12-18	5-10 additional pounds	Slower rate, approaching goal weight, final optimization

Factors Affecting Your Timeline

Faster weight loss (above average) may occur if you:

• Have a higher starting BMI
• Follow a structured diet and exercise program
• Tolerate higher doses well
• Are younger and have better baseline metabolic health

Slower weight loss (below average) may occur if you:

• Have metabolic conditions (PCOS, hypothyroidism, insulin resistance)
• Take medications that promote weight gain
• Are postmenopausal or older
• Can only tolerate lower doses
• Have a history of yo-yo dieting

For a detailed week-by-week and month-by-month breakdown, see our comprehensive tirzepatide timeline guide.

Cost and Affordability

Cost is often a major consideration when discussing tirzepatide with your clinician.

Brand-Name Pricing

Medication	Monthly Cost (Without Insurance)	Annual Cost
Zepbound (weight loss)	$1,060-1,200	$12,720-14,400
Mounjaro (diabetes)	$1,025-1,150	$12,300-13,800

Insurance Coverage Reality

For Type 2 Diabetes (Mounjaro):

• Better coverage; many insurance plans cover with prior authorization
• Average copay with coverage: $25-$50/month
• Manufacturer savings card may be available

For Weight Loss (Zepbound):

• Very limited insurance coverage
• Most plans exclude weight loss medications
• Medicare doesn’t cover medications for weight loss
• Some employer plans may cover with specific criteria

Compounded Tirzepatide

Important: Compounded tirzepatide is NOT FDA-approved. The FDA does not verify the safety or effectiveness of compounded medications. Compounded tirzepatide is prepared by a state-licensed 503A compounding pharmacy that prepares your medication individually, for you, based on your prescription, but compounded products are not individually FDA-approved (registration is not the same as approval).

Typical Compounded Pricing:

• Monthly cost: see current pricing on our compounded tirzepatide page (flat pricing across all dose levels)
• Flat pricing regardless of dose

What’s Typically Included:

• Medication from a state-licensed compounding pharmacy
• All necessary supplies (needles, alcohol swabs, sharps container)
• Medical oversight and provider consultations
• Flat pricing regardless of dose

For a complete cost breakdown, insurance strategies, and ways to save, see our comprehensive tirzepatide cost guide.

Brand-Name vs Compounded Tirzepatide

How Do Brand-Name and Compounded Tirzepatide Differ?

This is one of the most common questions patients ask. Compounded tirzepatide is NOT FDA-approved, and clinical trial data applies only to the FDA-approved branded products. Here’s what to know:

Factor	Brand-Name	Compounded
Active Ingredient	Tirzepatide	Tirzepatide
FDA Approval	Yes (Zepbound, Mounjaro)	No (NOT FDA-approved)
Clinical Testing	Extensive (SURMOUNT, SURPASS trials)	No independent clinical trials; trial data does not apply
Pharmacy Standards	FDA-regulated manufacturing	State-licensed compounding pharmacy (product not individually FDA-approved)
Quality Testing	Rigorous FDA standards	Third-party testing (potency, sterility) varies by pharmacy
Delivery Device	Pre-filled auto-injector pen	Vial with syringe or pen system
Cost	$1,000-1,200/month	See current pricing on our compounded tirzepatide page

Important: While the active ingredient is tirzepatide in both cases, compounded products are not FDA-approved and the safety and effectiveness data from the branded clinical trials cannot be assumed to apply to compounded tirzepatide.

About Compounding

Under the 503A pathway, a medication may be compounded for an individual patient when a clinician determines it’s appropriate. Other conditions also apply:

1. The legal and regulatory status of compounding is complex and subject to change
2. Discuss FDA-approved options with your healthcare provider
3. The medication must be prescribed by a licensed healthcare provider

Quality Considerations

Markers some patients look for when evaluating a provider:

• State-licensed compounding pharmacy
• Third-party potency testing (certificate of analysis provided)
• Sterility testing for batches
• Transparency about the manufacturing process
• Medical oversight included with the prescription

For detailed information about compounded tirzepatide quality standards and what to look for, see our complete compounded tirzepatide safety guide.

Safety and Contraindications

FDA Boxed Warning: Thyroid C-Cell Tumors

Tirzepatide carries an FDA boxed warning for possible thyroid C-cell tumors based on animal studies; the human risk is not determined. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Discuss your risk with your clinician.

What this means:

• Rodent studies showed increased thyroid C-cell tumors at certain doses
• Whether tirzepatide causes these tumors in humans has not been determined
• Do not use if: you have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
• Report symptoms such as a neck mass, trouble swallowing, hoarseness, or shortness of breath to your clinician

Long-Term Safety: What Is Known So Far

In clinical trials lasting up to about 2 years, the safety profile of FDA-approved tirzepatide was characterized; longer-term and real-world safety continues to be studied.

What clinical trials have characterized:

• Cardiovascular markers, including average reductions in blood pressure and improvements in lipids
• An ongoing cardiovascular outcomes trial (SURMOUNT-MMO) is expected to provide more data
• Extension studies are ongoing for additional years of data

Areas still being studied or monitored:

• Thyroid C-cell tumors (see boxed warning above)
• Pancreatitis (uncommon in trials)
• Long-term effects on bone density (limited data so far)
• Longer-term and real-world safety beyond the trial periods

Drug Interactions

Medications that may interact with tirzepatide:

Insulin and Sulfonylureas:

• Increased risk of hypoglycemia
• Dose reduction of insulin/sulfonylureas often needed
• Close blood sugar monitoring required

Oral Medications:

• Tirzepatide slows gastric emptying
• May affect absorption of some oral medications
• Discuss timing of critical medications with your clinician
• Particularly important to review: birth control pills, thyroid medication

Medications that promote weight gain:

• May reduce effectiveness of tirzepatide
• Examples: some antidepressants, antipsychotics, steroids, seizure medications
• Discuss alternatives with your doctor if appropriate

Long-Term Use Considerations

Is Tirzepatide a Lifelong Medication?

For many people, tirzepatide is used as a long-term treatment. Your clinician can help you decide what is right for you. Here’s the context:

Weight Regain After Stopping:

• Research suggests many people regain a substantial portion of lost weight within about 12 months of stopping
• Appetite hormones tend to return to pre-treatment levels
• Metabolic adaptations may persist

Maintenance Dosing Strategies (Clinician-Directed):

• Some people maintain weight loss on lower “maintenance” doses
• Example: reducing the dose after reaching goal weight, if your clinician agrees
• May allow sustained benefits while reducing costs (if paying out-of-pocket)
• May reduce long-term side effects for some people

Alternatives to Lifelong Treatment:

• Intensive lifestyle modification (structured exercise and dietary adherence)
• Medication “holidays” with close monitoring (carries risk of regain)
• Transitioning to other clinician-recommended options for maintenance

What Happens When You Stop Tirzepatide?

For detailed information about weight regain patterns, tapering strategies, and how to maximize your chances of maintaining weight loss if you decide to stop, see our comprehensive guide on stopping tirzepatide.

How to Get Started with Tirzepatide

Steps to Begin Treatment

1. Consultation with Healthcare Provider

• Discuss your weight loss goals and medical history
• Review medications and health conditions
• Determine if you qualify for tirzepatide
• Discuss brand-name vs compounded options, including that compounded tirzepatide is not FDA-approved

2. Obtain Prescription

• Provider prescribes an appropriate starting dose if suitable for you
• Prescription sent to pharmacy or telehealth provider
• Insurance prior authorization submitted if applicable

3. Receive Medication and Supplies

• Medication shipped with necessary supplies
• Includes needles, alcohol swabs, sharps container
• Storage instructions provided
• Injection training resources available

4. First Injection

• Many people prefer their first injection with guidance
• Review injection technique
• Understand side effect management
• Schedule follow-up for dose escalation

For step-by-step injection instructions, see our detailed tirzepatide injection guide.

Telehealth Options

Tirzepatide is increasingly discussed through telehealth platforms. These platforms may offer:

Potential Advantages:

• Convenient online consultations
• Medication shipped to your home
• Ongoing provider support via messaging
• Compounded options at lower cost (not FDA-approved)
• No in-person visits required

What to Look For:

• Licensed healthcare providers (MD, DO, NP, PA)
• State medical licensure verification
• Transparent pricing
• State-licensed compounding pharmacy
• Ongoing medical supervision included
• Clear communication channels

Contour Health’s Tirzepatide Program

At Contour Health, we provide tirzepatide weight management services with medical oversight:

• Medical Oversight: Licensed providers experienced with weight management medications
• Compounded Tirzepatide: see current pricing on our compounded tirzepatide page; medication is prepared by a state-licensed 503A compounding pharmacy that prepares your medication individually, for you, based on your prescription (compounded tirzepatide is NOT FDA-approved)
• All Supplies Included: Needles, syringes, alcohol swabs, sharps container
• Ongoing Support: Regular check-ins and clinician-directed dose optimization
• Flexible Dosing: Personalized escalation based on your tolerance and your clinician’s judgment
• No Hidden Fees: Transparent, flat-rate pricing at all dose levels

Learn more about our tirzepatide program and discuss whether it may be appropriate for you. Whether tirzepatide is right for you is a decision for you and a licensed clinician.

Related reading: Curious why some people use lower, personalized doses? Read Microdosing Semaglutide: The Honest Guide to Low-Dose, Personalized GLP-1 Care.

Frequently Asked Questions

How fast does tirzepatide work?

Experiences vary. In trials of FDA-approved tirzepatide, many people noticed reduced appetite within the first weeks, with more noticeable weight loss after the dose increased. Individual results vary, are not guaranteed, and may not apply to compounded tirzepatide. See our detailed timeline guide.

Is tirzepatide better than semaglutide?

In head-to-head trials of the FDA-approved branded products, tirzepatide produced greater average weight loss than semaglutide. These results apply to FDA-approved products and may not apply to compounded versions. Individual results vary based on adherence, diet, exercise, and your health history. Read our comprehensive comparison guide.

What are the most common side effects?

Nausea (30-40%), diarrhea (20-30%), and decreased appetite are among the most common side effects. Many are mild to moderate and improve within a few weeks for many people, though experiences vary. Serious side effects like pancreatitis are uncommon. Tirzepatide also carries an FDA boxed warning for possible thyroid C-cell tumors. See our complete side effects guide.

How much does tirzepatide cost?

Brand-name Zepbound costs roughly $1,060-1,200/month without insurance. For compounded tirzepatide (which is NOT FDA-approved), see current pricing on our compounded tirzepatide page; medical supervision is included. Insurance coverage for weight loss is very limited. See our detailed cost breakdown.

Can I take tirzepatide if I don’t have diabetes?

Zepbound is FDA-approved for weight loss in adults without diabetes who have a BMI ≥30, or BMI ≥27 with weight-related health conditions. You do not need diabetes to be considered for tirzepatide for weight loss. A licensed clinician will determine whether it is appropriate for you.

How long do I need to take tirzepatide?

Many clinicians view weight management medications as long-term treatments, but the right duration is an individual decision. Studies suggest many people regain a substantial portion of lost weight after stopping. Some people maintain weight loss on a lower “maintenance dose.” Make this decision with your healthcare provider based on your circumstances.

Is compounded tirzepatide safe?

Compounded tirzepatide is NOT FDA-approved. The FDA does not verify the safety or effectiveness of compounded medications, and clinical trial data from the branded products may not apply. Compounded tirzepatide is prepared by a state-licensed compounding pharmacy, but compounded products are not individually FDA-approved (registration is not the same as approval). Individual results vary. Discuss the risks and benefits with your clinician. Learn more in our compounded safety guide.

Can I drink alcohol while taking tirzepatide?

Discuss alcohol use with your clinician. Alcohol may worsen nausea and gastrointestinal side effects, add empty calories that slow weight loss, and increase the risk of hypoglycemia if you have diabetes. Many people naturally lose interest in alcohol while on tirzepatide due to reduced appetite and food reward.

Will tirzepatide cause hair loss?

Temporary hair thinning affects some people, but it is generally related to rapid weight loss and nutritional factors rather than the medication itself. This telogen effluvium typically occurs a few months after starting and often resolves once weight stabilizes. Adequate protein intake (100g+ daily) and biotin supplementation may help.

What happens if I miss a dose?

If you miss your weekly injection, take it as soon as you remember if it’s within 4 days of your scheduled dose. If more than 4 days have passed, skip that dose and resume your regular schedule. Never double up on doses, and follow the product instructions and your clinician’s guidance. See our complete guide on what to do if you miss a dose.

Can I take tirzepatide while pregnant or breastfeeding?

No. Tirzepatide should not be used during pregnancy or breastfeeding. If you’re planning to become pregnant, talk with your clinician about stopping tirzepatide before trying to conceive. Discuss alternative weight management strategies with your healthcare provider during pregnancy and breastfeeding.